ROTARIX liquid susp orale tb 1.5 ml

7680601500043 Pharmacode 7851144 CH-60150 J07BH01 08.08.

Reimbursement limitations:

AMLOVALSAND2

Le traitement combiné d’AMLODIPINE VALSARTAN SANDOZ et d'un antagoniste du calcium I.T. 02.06 et/ou d’un …

ROTARIX liquid susp orale tb 1.5 ml
ROTARIX liquid susp orale tb 1.5 ml
ROTARIX liquid susp orale tb 1.5 ml
1 / 3
google

Details

GTIN
7680601500043
Pharmacode
7851144
Product number
6015001
CPT
-
Packaging group
1
Unit
Einzeldose(n)
Composition
Vaccinum attenuatum: rotavirus humanus vivus attenuatum (Stamm: RIX4414) min 1 Mio U., saccharum 1073 mg, dinatrii adipas, Dulbecco's modified eagle medium cum phenylalaninum 15 µg et glucosum 0.01 mg, aqua ad iniectabile q.s. ad suspensionem pro 1.5 ml corresp. natrium 32 mg.

Articles (1)

Rotarix, Suspension zum Einnehmen
suspension
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
23/07/2026
Professional SmPC
Français
23/07/2026
Professional SmPC
Italien
23/07/2026

Detailed composition

Substance Quantity Type Category
rotavirus humanus vivus attenuatum
- Substance Wirkstoff (Principe actif)
saccharum
1073.0 MG Substance HBESI
dinatrii adipas
- Substance HNIDK
Dulbecco's modified eagle medium
- Substance HNIDK
phenylalaninum
15.0 UG Substance HBESI
glucosum
0.01 MG Substance HBESI
aqua ad iniectabile
- Substance HNIDK
natrium
32.0 MG Substance HBESI

Reimbursement information

Public price
CHF 59.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2024

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
60150
Drug name
Rotarix liquid, Suspension zum Einnehmen
Galenic form
SUOR
ATC Code
J07BH01
Authorization status
Z
Dispensation category
B
First authorization
14/05/2009
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
Aktive Immunisierung ab der vollendeten 6. Lebenswoche zur Vorbeugung von Gastroenteritiden durch Rotaviren der Serotypen G1 und nicht-G1 wie G2, G3, G4 und G9

Packaging details

Description (FR)
ROTARIX liquid susp orale tb 1.5 ml
Description (DE)
ROTARIX liquid Susp oral Tb 1.5 ml
Market launch
13/05/2009
Narcotic (BTM)
No

Application methods

ORA

Other packaging sizes

ROTARIX liquid susp min 1 Mio U. 1 ml
1 EINZ
View
ROTARIX liquid susp orale 10 tb 1.5 ml
10 EINZ
View
Buy us a coffee Explore the data